Higher in utero and perinatal HIV infection risk in girls than boys

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 4, 2006, Pages 509-513

  Biggar, Robert J ^a,f   Taha, Taha E ^b   Hoover, Donald R ^c   Yellin, Francis ^d   Kumwenda, Newton ^b   Broadhead, Robin ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d Computer Sciences Corp ^*  (United States)

^e UNIVERSITY OF MALAWI   (Malawi)

^f NONE   (United States)

Author keywords

Female; Gender; HLA; Infants; Male; Retrovirus; Vertical transmission

Indexed keywords

AFRICA; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE TRANSMISSION; EXPOSURE; FEMALE; GENDER; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; INTRAUTERINE INFECTION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALAWI; MALE; MINOR HISTOCOMPATIBILITY COMPLEX; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION; Y CHROMOSOME;

DISEASE SUSCEPTIBILITY; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT, NEWBORN; MALAWI; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; RNA, VIRAL; SEX CHARACTERISTICS; STATISTICS;

EID: 33646807143     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000191283.85578.46     Document Type: Article

References (21)

1. Thorne C, Newell ML, for the European Collaborative Study. Are girls more at risk of intrauterine-acquired HIV infection than boys? AIDS. 2004;18:344-347.
2. Taha TE, Nour S, Kumwenda NI, et al. Gender differences in perinatal HIV acquisition among African infants. Pediatrics. 2005;115: e167-e172.
3. Beau JP, Coulibaly I. HIV-related gender biases among malnourished children in Abidjan, Cote D'Ivoire. J Trop Pediatr. 1999;45:169-171.
4. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
5. Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003;362:859-868.
6. Coutsoudis A, Dabis F, Fawzi W, et al. Breastfeeding and HIV International Transmission Study Group. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis. 2004;189:2154-2166.
7. Biggar RJ, Miotti PG, Taha TE, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet. 1996;347:1647-1650.
8. Biggar RJ, Cassol S, Kumwenda N, et al. The risk of human immunodeficiency virus-1 infection in twin pairs born to infected mothers in Africa. J Infect Dis. 2003;188:850-855.
9. Taha TE, Biggar RJ, Broadhead RL, et al. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ. 1997;315:216-219.
10. Biggar RJ, Miley W, Miotti P, et al. Blood collection on filter paper: a practical approach to sample collection for studies of perinatal HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:368-373.
11. Biggar RJ, Janes M, Pilon R, et al. Virus levels in untreated African infants infected with human immunodeficiency virus type 1. J Infect Dis. 1999;180:1838-1843.
12. Biggar RJ, Wohlfahrt J, Westergaard T, et al. Sex ratios, family size, and birth order. Am J Epidemiol. 1999;150:957-962.
13. MacDonald KS, Embree J, Njenga S, et al. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis. 1998;177:551-556.
14. Polycarpou A, Ntais C, Korber BT, et al. Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. AIDS Res Hum Retroviruses. 2002;18:741-746.
15. Uphoff DE. Comparative survival of lethally irradiated inbred male mice inoculated with marrow from virgin or nulliparous female donors. J Natl Cancer Inst. 1975;54:1343-1347.
16. Gratwohl A, Hermans J, Niederwieser D, et al. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol J. 2001;2:363-370.
17. Urbano-Ispizua A, Rozman C, Pimentel P, et al. Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings. Blood. 2002;100:724-727.
18. Carlens S, Ringdén O, Remberger M, et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant. 1998;22:755-761.
19. Spierings E, Vermeulen CJ, Vogt MH, et al. Identification of HLA class II-restricted H-Y specific T-helper epitope evoking CD4+ helper-T cells in H-Y-mismatched transplantation. Lancet. 2003;352:610-615.
20. Rugeles MT, Trubey CM, Bedoya VI, et al. Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition. AIDS. 2003;17:481-486.
21. Rugeles MT, Shearer GM. Alloantigen recognition in utero: dual advantage for the fetus? Trends Immunol. 2004;25:348-352.